Pharma Works: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharma Works
Largest movements
- Cash +€49,462
up €49,462 (+56.9%), from €86,989 to €136,451
mainly Depreciation (+€56,562) and Net result for the year (+€19,165)
- Tangible fixed assets -€42,205
down €42,205 (-17.9%), from €236,293 to €194,088
of which Other tangible fixed assets: -€47,126
- Deferred charges and accrued income +€11,823
up €11,823 (+752.0%), from €1,572 to €13,395
- Profit (loss) carried forward +€19,165
up €19,165 (+126.9%), from €15,099 to €34,265
- Debts after one year -€12,370
down €12,370 (-4.3%), from €287,288 to €274,918
- Accrued charges and deferred income +€5,968
up €5,968 (+428.9%), from €1,391 to €7,359
- Tax, wage and social debts +€3,781
up €3,781 (+42.2%), from €8,963 to €12,744
- Financial charges -€16,482
down €16,482 (-97.0%), from €16,993 to €511
- Taxes +€3,877
up €3,877 (+149.9%), from €2,587 to €6,464
- Write-downs +€1,979
new in 2024: €1,979
- Depreciation +€1,899
up €1,899 (+3.5%), from €54,663 to €56,562
- Other operating charges -€983
down €983 (-19.8%), from €4,952 to €3,969
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €336,355 | €356,098 | +€19,743 | +5.9% |
| Fixed assets | 21/28 | €237,213 | €194,598 | -€42,615 | -18.0% |
| Tangible fixed assets | 22/27 | €236,293 | €194,088 | -€42,205 | -17.9% |
| Land and buildings | 22 | €38,690 | €47,567 | +€8,877 | +22.9% |
| Plant, machinery and equipment | 23 | €115 | €12 | -€103 | -89.9% |
| Furniture and vehicles | 24 | €8,925 | €5,073 | -€3,852 | -43.2% |
| Other tangible fixed assets | 26 | €188,563 | €141,436 | -€47,126 | -25.0% |
| Financial fixed assets | 28 | €920 | €510 | -€410 | -44.5% |
| Current assets | 29/58 | €99,142 | €161,500 | +€62,358 | +62.9% |
| Stocks and contracts in progress | 3 | €1,777 | €755 | -€1,022 | -57.5% |
| Stocks | 30/36 | €1,777 | €755 | -€1,022 | -57.5% |
| Amounts receivable within one year | 40/41 | €8,804 | €10,899 | +€2,096 | +23.8% |
| Trade receivables | 40 | €8,804 | €10,685 | +€1,881 | +21.4% |
| Other amounts receivable | 41 | €0 | €214 | +€214 | |
| Cash at bank and in hand | 54/58 | €86,989 | €136,451 | +€49,462 | +56.9% |
| Deferred charges and accrued income | 490/1 | €1,572 | €13,395 | +€11,823 | +752.0% |
| Total equity and liabilities | 10/49 | €336,355 | €356,098 | +€19,743 | +5.9% |
| Equity | 10/15 | €28,749 | €47,914 | +€19,165 | +66.7% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €11,150 | €11,150 | = | 0.0% |
| Tax-exempt reserves | 132 | €11,150 | €11,150 | = | 0.0% |
| Profit (loss) carried forward | 14 | €15,099 | €34,265 | +€19,165 | +126.9% |
| Provisions and deferred taxes | 16 | €8,000 | €8,000 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €8,000 | €8,000 | = | 0.0% |
| Major repairs and maintenance | 162 | €8,000 | €8,000 | = | 0.0% |
| Amounts payable | 17/49 | €299,606 | €300,183 | +€578 | +0.2% |
| Amounts payable after more than one year | 17 | €287,288 | €274,918 | -€12,370 | -4.3% |
| Financial debts | 170/4 | €287,288 | €274,918 | -€12,370 | -4.3% |
| Amounts payable within one year | 42/48 | €10,927 | €17,906 | +€6,979 | +63.9% |
| Trade debts | 44 | €1,964 | €1,729 | -€235 | -12.0% |
| Suppliers | 440/4 | €1,964 | €1,729 | -€235 | -12.0% |
| Advances received on contracts in progress | 46 | - | €2,423 | +€2,423 | |
| Taxes, remuneration and social security | 45 | €8,963 | €12,744 | +€3,781 | +42.2% |
| Taxes | 450/3 | €8,963 | €12,744 | +€3,781 | +42.2% |
| Other amounts payable | 47/48 | - | €1,010 | +€1,010 | |
| Accrued charges and deferred income | 492/3 | €1,391 | €7,359 | +€5,968 | +428.9% |
| Non-recurring operating income | 76A | €12,083 | €0 | -€12,083 | -100.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €54,663 | €56,562 | +€1,899 | +3.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €1,979 | +€1,979 | |
| Other operating charges | 640/8 | €4,952 | €3,969 | -€983 | -19.8% |
| Non-recurring operating charges | 66A | €7,963 | €477 | -€7,486 | -94.0% |
| Gross operating margin | 9900 | €89,281 | €88,415 | -€866 | -1.0% |
| Operating profit (loss) | 9901 | €21,703 | €25,426 | +€3,724 | +17.2% |
| Financial income | 75/76B | €82 | €715 | +€633 | +773.8% |
| Recurring financial income | 75 | €82 | €715 | +€633 | +773.8% |
| Financial charges | 65/66B | €16,993 | €511 | -€16,482 | -97.0% |
| Recurring financial charges | 65 | €16,993 | €511 | -€16,482 | -97.0% |
| Profit (loss) for the period before taxes | 9903 | €4,792 | €25,630 | +€20,838 | +434.9% |
| Income taxes | 67/77 | €2,587 | €6,464 | +€3,877 | +149.9% |
| Profit (loss) for the period | 9904 | €2,204 | €19,165 | +€16,961 | +769.4% |
| Profit (loss) for the period to be appropriated | 9905 | €2,204 | €19,165 | +€16,961 | +769.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.